Cost of quality management and information provision for screening: colorectal cancer screening

被引:7
作者
Robert, G [1 ]
Brown, J
Garvican, L
机构
[1] Brunel Univ, Hlth Econ Res Grp, Uxbridge UB8 3PH, Middx, England
[2] St Georges Hosp, Dept Publ Hlth Sci, Hlth Care Evaluat Unit, London, England
关键词
cost analysis; quality management; training; colorectal cancer;
D O I
10.1136/jms.7.1.31
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective-To estimate the costs of a qualify management (QM) system as proposed by the Quality Management for Screening report for a future national colorectal cancer screening programme. Methods-Estimates of the costs of the QM system, including the associated costs of education and training and information provision, were based on expert opinion, the existing literature, and the experience of the current National Health Service (NHS) breast cancer screening programme (BSP) and the NHS cervical cancer screening programme (CSP). Results-The cost of a QM system to support a national colorectal cancer programme in the UK was estimated as approximately pound 3.8 million a year. Further annual costs related to QM will include pound 500 000 for education and training and pound 200 000 for information provision. Adding these additional costs to a previously published UK economic evaluation of colorectal cancer screening increases the cost-utility ratio to approximately;pound 6500 per quality adjusted life year gained (over an eight year follow up period). Conclusions-Any new screening programme, or an existing one, must have QM to ensure that the quality of screening is high and to maintain the right balance between benefit and harm. The significant costs of such a QM system should be included in any economic evaluation of a screening programme.
引用
收藏
页码:31 / 34
页数:4
相关论文
共 8 条
[1]  
BALMER S, IN PRESS QUALITY MAN
[2]   Planning for a possible national colorectal cancer screening programme [J].
Garvican, L .
JOURNAL OF MEDICAL SCREENING, 1998, 5 (04) :187-194
[3]   The first report of the National Screening Committee [J].
Gray, JAM .
JOURNAL OF MEDICAL SCREENING, 1998, 5 (04) :169-169
[4]   Randomised controlled trial of faecal-occult-blood screening for colorectal cancer [J].
Hardcastle, JD ;
Chamberlain, JO ;
Robinson, MHE ;
Moss, SM ;
Amar, SS ;
Balfour, TW ;
James, PD ;
Mangham, CM .
LANCET, 1996, 348 (9040) :1472-1477
[5]   Generalizing costs from trials - Analyzing center selection bias in a breast screening trial [J].
Johnston, K ;
Gerard, K ;
Brown, J .
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 1998, 14 (03) :494-504
[6]  
*NHS EX, 1997, EL9766 NHS EX
[7]  
Whynes DK, 1998, HEALTH ECON, V7, P21, DOI 10.1002/(SICI)1099-1050(199802)7:1<21::AID-HEC306>3.0.CO
[8]  
2-9